🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07035093
Active, not recruiting Phase 3

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 · tracked via the Priya Life Science USA tracker
Sponsor
Eli Lilly and Company
Phase
Phase 3
Started
2025-05-29
Last updated
2026-07-23

Condition(s) studied

ObesityOverweightChronic Low Back Pain (CLBP)

Investigational drug(s) / intervention(s)

RetatrutidePlacebo

Retatrutide: Administered SC

Placebo: Administered SC

Study summary

The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Have a history of axial-predominant low back pain * Have pain that is restricted to the low back or with a referral pattern limited to the proximal legs * Have a body mass index (BMI) ≥27 kilograms per square meter (kg/m2) at screening * Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight Exclusion Criteria: * Have a non-axial origin low back pain * Have had botulinum or steroid injections to the spine within 1 year of screening * Have had trigger point injection to the spine within 6 months of screening * Have a self-reported change in body weight \>5 kilograms (kg) (11 pounds) within 90 days prior to screening * Have been taking drugs to promote body weight reduction, including over-the-counter medications, within 90 days prior to screening * Have a prior or planned surgical treatment for obesity * Have Type 1 Diabetes, Type 2 Diabetes, or any other type of diabetes

Primary outcome measure(s)

Trial sites (40)

FacilityCityRegionStatus
MD First Research - Chandler Chandler Arizona
Tucson Orthopaedic Institute - North Wyatt Drive Tucson Arizona
Ark Clinical Research - Fountain Valley Fountain Valley California
St Joseph Heritage Healthcare Fullerton California
Clinical Research Institute Los Angeles California
Artemis Institute for Clinical Research San Diego California
Alpine Clinical Research Center Boulder Colorado
K2 Medical Research - Daytona Beach Daytona Beach Florida
Flourish Research - Miami, LLC Miami Florida
IMA Clinical Research St. Petersburg St. Petersburg Florida
Care Access - Tampa Tampa Florida
Charter Research - Lady Lake The Villages Florida
Conquest Research Winter Park Florida
Cotton O'Neil Clinical Research Center Topeka Kansas
Care Access - Lake Charles (Bayou Pines) Lake Charles Louisiana
MedVadis Research Corporation Waltham Massachusetts
Great Lakes Research Group, Inc. Bay City Michigan
Clinvest Headlands Llc Springfield Missouri
Center for Clinical Research Winston-Salem North Carolina
Altoona Center For Clinical Research Duncansville Pennsylvania
New Phase Research and Development Knoxville Tennessee
FutureSearch Trials of Neurology Austin Texas
Mercy Family Clinic Dallas Texas
Houston Research Institute Houston Texas
Sovah Clinical Research-River District Danville Virginia
Investigaciones Medicas Imoba Srl Buenos Aires Argentina
CIPREC Buenos Aires Argentina
Centro Médico Viamonte Buenos Aires Argentina
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada Buenos Aires Argentina
Fundación Respirar Buenos Aires Argentina
Centro de Investigaciones Clínicas Baigorria Granadero Baigorria Argentina
Centro Rosarino de Investigaciones Clinicas (CRICs) Rosario Argentina
Instituto Médico Catamarca IMEC Rosario Argentina
Centro de Diagnóstico y Rehabilitación (CEDIR) Santa Fe Argentina
Aggarwal and Associates Limited Brampton Canada
Winterberry Research Inc. Hamilton Canada
Bluewater Clinical Research Group Inc. Sarnia Canada
Care Access - Cape Breton Sydney Canada
Dr. Anil K. Gupta Medicine Professional Corporation Toronto Canada
Podlaskie Centrum Psychogeriatrii Bialystok Poland

More Eli Lilly and Company trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07035093 on ClinicalTrials.gov ↗ ← All trials in the USA